Fierce Pharma Asia—Takeda’s narcolepsy trial problem, gene therapy pact; human error in Moderna’s COVID vaccine
Fierce Pharma Asia—Takeda’s narcolepsy trial problem, gene therapy pact; human [...]
Fierce Pharma Asia—Takeda’s narcolepsy trial problem, gene therapy pact; human [...]
New FDA chief set to be nominated by Biden, 9 [...]
Alvotech scores in AbbVie trade secrets case, but the Humira [...]
Pilot launch complete: GlaxoSmithKline’s malaria shot scores WHO backing for [...]
Biogen, mRNA players on Merck’s M&A radar as CEO still [...]
Buyers clamor for Merck’s COVID-19 antiviral molnupiravir, but pricing is [...]
Biohaven’s Nurtec, with dual migraine approvals, hits $136M in quarterly [...]
GlaxoSmithKline relocates U.S. operations in Philadelphia, North Carolina as COVID-19 [...]
Bayer pledges $464M to upgrade, build production facilities in contraceptives [...]
AstraZeneca underpaid hundreds of female and Hispanic sales reps, feds [...]